PMC:7105881 / 22152-22391
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 708 | 37-45 | Species | denotes | SARS-CoV | Tax:694009 |
| 709 | 50-58 | Species | denotes | MERS-CoV | Tax:1335626 |
| 710 | 178-186 | Species | denotes | SARS-CoV | Tax:694009 |
| 711 | 191-199 | Species | denotes | MERS-CoV | Tax:1335626 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T85 | 37-45 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T86 | 178-186 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T240 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T135 | 0-137 | Sentence | denotes | A number of subunit vaccines against SARS-CoV and MERS-CoV have been developed, and these are described in detail in the next paragraphs. |
| T136 | 138-239 | Sentence | denotes | The targets used for the development of SARS-CoV and MERS-CoV subunit vaccines are also be discussed. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T422 | 37-45 | SP_10 | denotes | SARS-CoV |
| T423 | 50-58 | SP_9 | denotes | MERS-CoV |
| T424 | 178-186 | SP_10 | denotes | SARS-CoV |
| T425 | 191-199 | SP_9 | denotes | MERS-CoV |
| T18365 | 37-45 | SP_10 | denotes | SARS-CoV |
| T63775 | 50-58 | SP_9 | denotes | MERS-CoV |
| T9525 | 178-186 | SP_10 | denotes | SARS-CoV |
| T91816 | 191-199 | SP_9 | denotes | MERS-CoV |